GBI Research, a leading business intelligence provider, has released its latest research, “HIV/AIDS Therapeutics Market to 2018 - Despite Major Patent Expiries, Increased Uptake of Once-a-Day Fixed-dose Combination Drugs to Drive Growth”. The report provides insights into the Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome) HIV/AIDS therapeutics market including market forecasts up to 2018. It provides an in-depth analysis of the major marketed products, as well as insights into the HIV/AIDS therapeutics R&D pipeline. The report provides in-depth analysis of the unmet needs, ... read the full abstract

More Prescription Drugs reports by GBI Research

Taiwan Pharmaceutical Market Outlook 2013 by GBI Research

Taiwan Pharmaceutical Market Outlook 2013SummaryGBI Research, the leading business intelligence provider, has released its latest research Taiwan Pharmaceutical Market Outlook 2013. The report focuses on ...